Cardio Diagnostics Holdings, Inc. (CDIO)
- Previous Close
0.2500 - Open
0.2599 - Bid 0.1802 x 200
- Ask 0.2860 x 200
- Day's Range
0.2185 - 0.2600 - 52 Week Range
0.1710 - 3.5600 - Volume
22,979,569 - Avg. Volume
695,606 - Market Cap (intraday)
5.278M - Beta (5Y Monthly) 4.81
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4000 - Earnings Date Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.00
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
cardiodiagnosticsinc.comRecent News: CDIO
View MorePerformance Overview: CDIO
Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CDIO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CDIO
View MoreValuation Measures
Market Cap
5.28M
Enterprise Value
4.74M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
104.50
Price/Book (mrq)
1.72
Enterprise Value/Revenue
121.23
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-97.95%
Return on Equity (ttm)
-293.27%
Revenue (ttm)
39.14k
Net Income Avi to Common (ttm)
-8.77M
Diluted EPS (ttm)
-0.4000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.31M
Total Debt/Equity (mrq)
28.31%
Levered Free Cash Flow (ttm)
-5.92M